Literature DB >> 22355050

Targeting adjuvant chemotherapy: a good idea that needs to be proven!

Daniel F Hayes1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22355050     DOI: 10.1200/JCO.2011.38.4529

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  19 in total

1.  Cost-Effectiveness Analyses of the 21-Gene Assay in Breast Cancer: Systematic Review and Critical Appraisal.

Authors:  Shi-Yi Wang; Weixiong Dang; Ilana Richman; Sarah S Mougalian; Suzanne B Evans; Cary P Gross
Journal:  J Clin Oncol       Date:  2018-04-16       Impact factor: 44.544

Review 2.  Indications for prognostic gene expression profiling in early breast cancer.

Authors:  Erin F Cobain; Daniel F Hayes
Journal:  Curr Treat Options Oncol       Date:  2015-05

Review 3.  Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Lyndsay N Harris; Nofisat Ismaila; Lisa M McShane; Fabrice Andre; Deborah E Collyar; Ana M Gonzalez-Angulo; Elizabeth H Hammond; Nicole M Kuderer; Minetta C Liu; Robert G Mennel; Catherine Van Poznak; Robert C Bast; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

4.  Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.

Authors:  Richard R Love; Adriano V Laudico; Nguyen Van Dinh; D Craig Allred; Gemma B Uy; Le Hong Quang; Jonathan Disraeli S Salvador; Stephen Sixto S Siguan; Maria Rica Mirasol-Lumague; Nguyen Dinh Tung; Noureddine Benjaafar; Narciso S Navarro; Tran Tu Quy; Arturo S De La Peña; Rodney B Dofitas; Orlino C Bisquera; Nguyen Dieu Linh; Ta Van To; Gregory S Young; Erinn M Hade; David Jarjoura
Journal:  J Natl Cancer Inst       Date:  2015-03-19       Impact factor: 13.506

Review 5.  Biomarker enrichment strategies: matching trial design to biomarker credentials.

Authors:  Boris Freidlin; Edward L Korn
Journal:  Nat Rev Clin Oncol       Date:  2013-11-26       Impact factor: 66.675

Review 6.  Publication of tumor marker research results: the necessity for complete and transparent reporting.

Authors:  Lisa M McShane; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

Review 7.  Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.

Authors:  Oluwadamilola M Fayanju; Ko Un Park; Anthony Lucci
Journal:  Ann Surg Oncol       Date:  2017-11-20       Impact factor: 5.344

8.  Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancer.

Authors:  Malek B Hannouf; Gregory S Zaric; Phillip Blanchette; Christine Brezden-Masley; Mike Paulden; Christopher McCabe; Jacques Raphael; Muriel Brackstone
Journal:  Pharmacogenomics J       Date:  2019-05-27       Impact factor: 3.550

9.  A nomogram to predict adjuvant chemotherapy recommendation in breast cancer patients with intermediate recurrence score.

Authors:  Feilin Qu; Xiaosong Chen; Xiaochun Fei; Lin Lin; Weiqi Gao; Yu Zong; Jiayi Wu; Ou Huang; Jianrong He; Li Zhu; Weiguo Chen; Yafen Li; Kunwei Shen
Journal:  Chin J Cancer Res       Date:  2018-04       Impact factor: 5.087

10.  Recommendations from the EGAPP Working Group: does the use of Oncotype DX tumor gene expression profiling to guide treatment decisions improve outcomes in patients with breast cancer?

Authors: 
Journal:  Genet Med       Date:  2015-12-17       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.